Subdermal Delivery Systems for Narcotic Antagonists - Colin Pitt

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute on Drug Abuse (NIDA)
Type: Research Project (R01)
Project #: 5R01DA003616-08
Application #: 2116775
Study Section: Drug Abuse Biomedical Research Review Committee (DABR)

Project Start: 1988-09-30
Project End: 1993-08-31
Budget Start: 1992-09-15
Budget End: 1993-08-31
Support Year: 8
Fiscal Year: 1992
Total Cost
Indirect Cost

Institution

Name: Amgen, Inc.
Department
Type
DUNS #

City: Thousand Oaks
State: CA
Country: United States
Zip Code: 91320

Related projects


NIH 1992 R01 DA	Subdermal Delivery Systems for Narcotic Antagonists Pitt, Colin G. / Amgen, Inc.
NIH 1991 R01 DA	Subdermal Delivery Systems for Narcotic Antagonists Pitt, Colin G. / Amgen, Inc.
NIH 1990 R01 DA	Subdermal Delivery Systems for Narcotic Antagonists Pitt, Colin G. / Amgen, Inc.
NIH 1989 R01 DA	Subdermal Delivery Systems for Narcotic Antagonists Pitt, Colin G. / Amgen, Inc.
NIH 1988 R01 DA	Subdermal Delivery Systems for Narcotic Antagonists Pitt, Colin G. / Research Triangle Institute
NIH 1986 R01 DA	Subdermal Delivery Systems for Narcotic Antagonists Pitt, Colin G. / Research Triangle Institute
NIH 1985 R01 DA	Subdermal Delivery Systems for Narcotic Antagonists Pitt, Colin G. / Research Triangle Institute

Publications

Shah, S S; Zhu, K J; Pitt, C G (1994) Poly-DL-lactic acid: polyethylene glycol block copolymers. The influence of polyethylene glycol on the degradation of poly-DL-lactic acid. J Biomater Sci Polym Ed 5:421-31

Pitt, C G; Song, X C; Sik, R et al. (1991) Spin labels as a probe of the molecular environment of covalently bound ligands in an hydrophobic and an hydrophilic polymer. Biomaterials 12:715-21

Cha, Y; Pitt, C G (1990) The biodegradability of polyester blends. Biomaterials 11:108-12

Comments

Be the first to comment on this grant